IDH2 and central nervous system cancer: Within low-grade gliomas and secondary glioblastoma, 2HG is often produced due to mutations in the catalytic domains of isocitrate dehydrogenase isoform 1 (IDH1) and isocitrate dehydrogenase isoform 2 (IDH2).